These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 17498290

  • 21. ADAMTS-5 and intervertebral disc degeneration: the results of tissue immunohistochemistry and in vitro cell culture.
    Zhao CQ, Zhang YH, Jiang SD, Li H, Jiang LS, Dai LY.
    J Orthop Res; 2011 May; 29(5):718-25. PubMed ID: 21437951
    [Abstract] [Full Text] [Related]

  • 22. Expression of proteinase-activated receptor-2 in the intervertebral disc.
    Iida R, Akeda K, Kasai Y, Masuda K, Morimoto R, Sakakibara T, Sato M, Uchida A.
    Spine (Phila Pa 1976); 2009 Mar 01; 34(5):470-8. PubMed ID: 19247167
    [Abstract] [Full Text] [Related]

  • 23. Toll-like receptor 2 induced senescence in intervertebral disc cells of patients with back pain can be attenuated by o-vanillin.
    Mannarino M, Cherif H, Li L, Sheng K, Rabau O, Jarzem P, Weber MH, Ouellet JA, Haglund L.
    Arthritis Res Ther; 2021 Apr 16; 23(1):117. PubMed ID: 33863359
    [Abstract] [Full Text] [Related]

  • 24. Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study.
    Le Maitre CL, Hoyland JA, Freemont AJ.
    Arthritis Res Ther; 2007 Apr 16; 9(4):R83. PubMed ID: 17760968
    [Abstract] [Full Text] [Related]

  • 25. Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degeneration.
    Pockert AJ, Richardson SM, Le Maitre CL, Lyon M, Deakin JA, Buttle DJ, Freemont AJ, Hoyland JA.
    Arthritis Rheum; 2009 Feb 16; 60(2):482-91. PubMed ID: 19180493
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. 2002 SSE Award Competition in Basic Science: expression of major matrix metalloproteinases is associated with intervertebral disc degradation and resorption.
    Weiler C, Nerlich AG, Zipperer J, Bachmeier BE, Boos N.
    Eur Spine J; 2002 Aug 16; 11(4):308-20. PubMed ID: 12193991
    [Abstract] [Full Text] [Related]

  • 28. Expression of semaphorin 3A and its receptors in the human intervertebral disc: potential role in regulating neural ingrowth in the degenerate intervertebral disc.
    Tolofari SK, Richardson SM, Freemont AJ, Hoyland JA.
    Arthritis Res Ther; 2010 Aug 16; 12(1):R1. PubMed ID: 20051117
    [Abstract] [Full Text] [Related]

  • 29. Expression of heparanase isoforms in intervertebral discs classified according to Pfirrmann grading system for disc degeneration.
    Rodrigues LM, Oliveira LZ, Pinhal MA.
    Spine (Phila Pa 1976); 2013 Jun 01; 38(13):1112-8. PubMed ID: 23370684
    [Abstract] [Full Text] [Related]

  • 30. Expression of cartilage-derived morphogenetic protein in human intervertebral discs and its effect on matrix synthesis in degenerate human nucleus pulposus cells.
    Le Maitre CL, Freemont AJ, Hoyland JA.
    Arthritis Res Ther; 2009 Jun 01; 11(5):R137. PubMed ID: 19754961
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Human nucleus pulposus intervertebral disc cells becoming senescent using different treatments exhibit a similar transcriptional profile of catabolic and inflammatory genes.
    Vamvakas SS, Mavrogonatou E, Kletsas D.
    Eur Spine J; 2017 Aug 01; 26(8):2063-2071. PubMed ID: 28646455
    [Abstract] [Full Text] [Related]

  • 35. Senotherapeutic drugs for human intervertebral disc degeneration and low back pain.
    Cherif H, Bisson DG, Mannarino M, Rabau O, Ouellet JA, Haglund L.
    Elife; 2020 Aug 21; 9():. PubMed ID: 32821059
    [Abstract] [Full Text] [Related]

  • 36. Interleukin-1 receptor antagonist deficient mice provide insights into pathogenesis of human intervertebral disc degeneration.
    Phillips KL, Jordan-Mahy N, Nicklin MJ, Le Maitre CL.
    Ann Rheum Dis; 2013 Nov 21; 72(11):1860-7. PubMed ID: 23396662
    [Abstract] [Full Text] [Related]

  • 37. Ex vivo observation of human intervertebral disc tissue and cells isolated from degenerated intervertebral discs.
    Ciapetti G, Granchi D, Devescovi V, Leonardi E, Greggi T, Di Silvestre M, Baldini N.
    Eur Spine J; 2012 May 21; 21 Suppl 1(Suppl 1):S10-9. PubMed ID: 22395304
    [Abstract] [Full Text] [Related]

  • 38. Disc cell senescence in intervertebral disc degeneration: Causes and molecular pathways.
    Feng C, Liu H, Yang M, Zhang Y, Huang B, Zhou Y.
    Cell Cycle; 2016 Jul 02; 15(13):1674-84. PubMed ID: 27192096
    [Abstract] [Full Text] [Related]

  • 39. p16 deficiency attenuates intervertebral disc degeneration by adjusting oxidative stress and nucleus pulposus cell cycle.
    Che H, Li J, Li Y, Ma C, Liu H, Qin J, Dong J, Zhang Z, Xian CJ, Miao D, Wang L, Ren Y.
    Elife; 2020 Mar 03; 9():. PubMed ID: 32125276
    [Abstract] [Full Text] [Related]

  • 40. p16Ink4a deletion in cells of the intervertebral disc affects their matrix homeostasis and senescence associated secretory phenotype without altering onset of senescence.
    Novais EJ, Diekman BO, Shapiro IM, Risbud MV.
    Matrix Biol; 2019 Sep 03; 82():54-70. PubMed ID: 30811968
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.